Edgewell Sells Feminine Care for $340M as Q1 Adjusted EPS Beats but Revenue Misses
Edgewell’s Q1 fiscal 2026 adjusted EPS loss was –$0.16, beating the –$0.18 consensus by 11.1% while GAAP EPS was –$1.41 on $422.8M continuing-operations revenue, a 12.2% shortfall versus estimates. The company sold its Feminine Care business for $340M to concentrate on core personal care categories and boost its balance sheet.
1. Q1 Financial Results
Edgewell reported GAAP EPS of –$1.41 and an adjusted EPS loss of –$0.16 for Q1 fiscal 2026, outperforming the –$0.18 consensus by 11.1%. Continuing-operations revenue reached $422.8M, missing estimates by 12.2%, while consolidated net sales rose 1.8% to $486.8M and organic sales declined 0.5%.
2. Divestiture of Feminine Care
On February 2, 2026, Edgewell completed the $340M sale of its Feminine Care business, enabling the company to sharpen its focus on shave, sun and skin care, and grooming segments. Management highlighted the divestiture as a pivotal step in its strategic transformation and streamlined portfolio strategy.
3. Balance Sheet and Outlook
Proceeds from the divestiture reduced net debt and enhanced liquidity, reflected in a current ratio of 2.12 and a debt-to-equity ratio of 1.05. A negative trailing P/E of –23.96 and a P/S of 0.42 underscore valuation challenges as Edgewell pursues cost savings and margin expansion in its core categories.